ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
72 hedge funds and large institutions have $67M invested in Anthera Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
72
Holding in Top 10
1
Calls
$738K
Puts
$502K
Top Buyers
| 1 | +$805K | |
| 2 | +$519K | |
| 3 | +$360K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$259K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$239K |
Top Sellers
| 1 | -$5.15M | |
| 2 | -$463K | |
| 3 | -$278K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$254K |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$152K |